(Q34349745)

1 August 2017

title

Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases (English)

1 reference

1 August 2017

0 references

Vijayendra Dasari

1

1 reference

1 August 2017

Corey Smith

series ordinal

2

1 reference

1 August 2017

Rajiv Khanna

series ordinal

3

1 reference

1 August 2017

publication date

1 June 2013

1 reference

Expert Review of Vaccines

1 August 2017

published in

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

661-676

1 reference

Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature

1 August 2017

cites work

1 reference

Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity

21 January 2018

1 reference

Cytomegalovirus strain diversity in seropositive women

21 January 2018

1 reference

Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection.

21 January 2018

1 reference

New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection

21 January 2018

1 reference

Maternal immunity and prevention of congenital cytomegalovirus infection

21 January 2018

1 reference

Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences

21 January 2018

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

Cytomegalovirus in transplantation - challenging the status quo.

21 January 2018

1 reference

Monitoring human cytomegalovirus infection in transplant recipients

21 January 2018

1 reference

Cytomegalovirus infection and reinfection transmitted by heart transplantation

21 January 2018

1 reference

Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels.

21 January 2018

1 reference

High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma

21 January 2018

1 reference

Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target

21 January 2018

1 reference

Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes

21 January 2018

1 reference

A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study

21 January 2018

1 reference

Persistent infection, inflammation, and functional impairment in older Latinos

21 January 2018

1 reference

Cytomegalovirus and human immunosenescence

21 January 2018

1 reference

Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients

21 January 2018

1 reference

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

21 January 2018

1 reference

Ad-gBCMVpoly: A novel chimeric vaccine strategy for human cytomegalovirus-associated diseases

21 January 2018

1 reference

Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects

21 January 2018

1 reference

Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus

21 January 2018

1 reference

The human cytomegalovirus.

21 January 2018

1 reference

Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1.

21 January 2018

1 reference

Recognition of herpesviruses by the innate immune system

21 January 2018

1 reference

Immunobiology of human cytomegalovirus: from bench to bedside.

21 January 2018

1 reference

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

21 January 2018

1 reference

Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection

21 January 2018

1 reference

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

21 January 2018

1 reference

Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection

21 January 2018

1 reference

Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin

21 January 2018

1 reference

HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors

21 January 2018

1 reference

Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

21 January 2018

1 reference

Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection

21 January 2018

1 reference

Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene

21 January 2018

1 reference

Cellular immune selection with hepatitis C virus persistence in humans

21 January 2018

1 reference

Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients

21 January 2018

1 reference

Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

Understanding human T-cell-mediated immunoregulation through herpesviruses

21 January 2018

1 reference

Contemporaneous fluctuations in T cell responses to persistent herpes virus infections

21 January 2018

1 reference

Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.

21 January 2018

1 reference

Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals.

21 January 2018

1 reference

Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection

21 January 2018

1 reference

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus

21 January 2018

1 reference

Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland

21 January 2018

1 reference

A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain).

21 January 2018

1 reference

Development of a cytomegalovirus vaccine: lessons from recent clinical trials

21 January 2018

1 reference

Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee

21 January 2018

1 reference

Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12.

21 January 2018

1 reference

Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy

21 January 2018

1 reference

Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine

21 January 2018

1 reference

Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers

21 January 2018

1 reference

Vaccine prevention of maternal cytomegalovirus infection

21 January 2018

1 reference

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

21 January 2018

1 reference

Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant

21 January 2018

1 reference

Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.

21 January 2018

1 reference

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.

21 January 2018

1 reference

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

21 January 2018

1 reference

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults

21 January 2018

1 reference

Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus

21 January 2018

1 reference

Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins

21 January 2018

1 reference

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice.

21 January 2018

1 reference

Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant

21 January 2018

1 reference

Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus

21 January 2018

1 reference

Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

21 January 2018

1 reference

Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques

21 January 2018

1 reference

A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.

21 January 2018

1 reference

Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.

21 January 2018

1 reference

A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.

21 January 2018

1 reference

Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression

21 January 2018

1 reference

Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant.

21 January 2018

1 reference

Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus

21 January 2018

1 reference

Towards a novel vaccine against human cytomegalovirus based on a chimeric Ad5F35 adenovirus vector expressing the immunodominant antigenic domain 1 epitope

21 January 2018

1 reference

Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.

21 January 2018

1 reference

Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes

21 January 2018

1 reference

Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.

21 January 2018

1 reference

Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines

21 January 2018

1 reference

Bacterial artificial chromosome clones of viruses comprising the towne cytomegalovirus vaccine

21 January 2018

1 reference

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

21 January 2018

1 reference

Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies

21 January 2018

1 reference

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

21 January 2018

1 reference

Update on the current status of cytomegalovirus vaccines

21 January 2018

1 reference

Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.

21 January 2018

1 reference

Encouraging prospects for immunisation against primary cytomegalovirus infection.

21 January 2018

1 reference

Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection

21 January 2018

1 reference

Attenuated vaccines can recombine to form virulent field viruses

21 January 2018

1 reference

Immunologic basis of vaccine vectors

21 January 2018

1 reference

Cytomegalovirus reinfections in healthy seroimmune women

21 January 2018

1 reference

Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus

21 January 2018

1 reference

Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients.

21 January 2018

1 reference

Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus

21 January 2018

1 reference

Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus.

21 January 2018

1 reference

Combination adjuvants: the next generation of adjuvants?

21 January 2018

1 reference

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

Systems biology of vaccination for seasonal influenza in humans

21 January 2018

1 reference

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population

21 January 2018

1 reference

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus

21 January 2018

1 reference

Could a vaccine against immune-evading cytomegalovirus become a reality?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.13.46

1 reference

1 August 2017

1 reference